CSIMarket
 
Mangoceuticals Inc   (NASDAQ: MGRX)
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare
 

Mangoceuticals Inc's Customers Performance

MGRX



 
MGRX's Source of Revenues During the corresponding time, Mangoceuticals Inc saw a revenue deteriorated by -59.1 % year on year, sequentially revenue grew by 1.32 %. While revenue at the Mangoceuticals Inc 's corporate clients

List of MGRX Customers




for the same period Mangoceuticals Inc revnue deteriorated by -59.1 % year on year, sequentially revenue grew by 1.32 %.

List of MGRX Customers

Mangoceuticals Inc's Business Units






Mangoceuticals Inc's Comment on Sales, Marketing and Customers



The company develops, markets, and sells men's wellness products and services through a telemedicine platform, focusing on erectile dysfunction (ED), hair loss, testosterone replacement or enhancement therapies, and weight management treatments. Its product brands include Mango (ED products), Grow (hair loss products), Mojo (hormone balance and therapy products), and Slim (weight loss products), collectively referred to as the Compounded Products. These products are produced and fulfilled by Epiq Scripts, LLC, a related-party compounding pharmacy. The Mango ED product contains ingredients such as Sildenafil or Tadalafil, Oxytocin, and L-Arginine, available in two dosage levels prescribed by physicians based on patient needs. The products are sold under an exemption of the Federal Food, Drug, and Cosmetic Act and require a physician's prescription.





Mangoceuticals Inc’s Comment on Sales, Marketing and Customers


The company develops, markets, and sells men's wellness products and services through a telemedicine platform, focusing on erectile dysfunction (ED), hair loss, testosterone replacement or enhancement therapies, and weight management treatments. Its product brands include Mango (ED products), Grow (hair loss products), Mojo (hormone balance and therapy products), and Slim (weight loss products), collectively referred to as the Compounded Products. These products are produced and fulfilled by Epiq Scripts, LLC, a related-party compounding pharmacy. The Mango ED product contains ingredients such as Sildenafil or Tadalafil, Oxytocin, and L-Arginine, available in two dosage levels prescribed by physicians based on patient needs. The products are sold under an exemption of the Federal Food, Drug, and Cosmetic Act and require a physician's prescription.








MGRX's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Mangoceuticals Inc 7.74 0.41 -19.21 22
SUBTOTAL 0.00 0.00 0.00 -

Sources: Mangoceuticals Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Mangoceuticals Inc’s corporate clients.
For your research, we’ve provided 9 tables on Mangoceuticals Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.